Gapping up
In reaction to strong earnings/guidance: IO +23.8%, ARCW +13.4%, SKX +13.4%, GNRC +7.2%, AVP +6.2% (also WSJ.com reporting potential AVP bribery settlement), NEWP +5.4%, MET +4.9% (light volume), CBS +4.3%, ( announces plans for a $1.5 billion accelerated share repurchase), NVDA +4%, (upgraded to Buy from Neutral at B. Riley & Co), Z +4%, MOH +3.3%, Q+3.2%, TOWR +2.8%, ABX +2.3%, GT +2%, HIMX +1.7%, TAL +1.6%, CAKE +1.5%, SPRT +1.4%, (light volume), ECA +1.2%, WWAV +1% (light volume), NRP +1% (light volume), SHPG +1% (also increased dividend), PBF +0.9% (light volume), ROVI +0.8%, AMAT +0.5%, RIO +0.4%, MPEL +0.5% (also disclosed that mgmt has recommended the payment of a special dividend).
M&A news: RTRX +33.4% ( announces agreement to acquire Manchester Pharmaceuticals for $62.5 mln), TWC +9.6% (Time Warner Cable confirms merger with Comcast (CMCSA) in a stock-for-stock transaction amounting to ~ $45.2 bln in equity value).
Cable/broadcasting names higher following TWC / CMCSA news: TWX +4.6% ,CVC +4.3%
Other news: BIOD +15.5% (announces plans to advance BIOD-531 Based on Positive Clinical Trial Results), OXBT +10.7% ( Newly Published Cardiac Surgery Study Provides Further Evidence that Levosimendan Significantly Improves Post-operative Kidney Function), PAL +10% (reports positive production ramp up progress), RMTI +4.4% (continued strength), ACHN +2.5% (continued strength), SFXE +2.3% ( Acquires 50% of Rock in Rio for $62.3 mln), INO +1.9% (was under pressure in afternoon trade), GALE +1.6% (CEO at Leerink Conference addresses negative blog article published today: 'just another in a long line of these'), CASY +0.6% (to acquire 24 Stop-n-Go Stores; 'acquisition will be accretive to earnings in the first year of operation'), SFG +0.6% (announces new 3 mln share repurchase authorization ), HOLX +0.4% (CEO discloses buying 38.6K shares at $20.97-21.71 on 2/10-2/11, worth ~$800K).
Analyst comments: NSPH +1.3% (upgraded to Buy from Neutral at ROTH Capital) ANR +0.8% (upgraded to Neutral from Underperform at Macquarie; resumed with Neutral at JP Morgan).
M&A news: RTRX +33.4% ( announces agreement to acquire Manchester Pharmaceuticals for $62.5 mln), TWC +9.6% (Time Warner Cable confirms merger with Comcast (CMCSA) in a stock-for-stock transaction amounting to ~ $45.2 bln in equity value).
Cable/broadcasting names higher following TWC / CMCSA news: TWX +4.6% ,CVC +4.3%
Other news: BIOD +15.5% (announces plans to advance BIOD-531 Based on Positive Clinical Trial Results), OXBT +10.7% ( Newly Published Cardiac Surgery Study Provides Further Evidence that Levosimendan Significantly Improves Post-operative Kidney Function), PAL +10% (reports positive production ramp up progress), RMTI +4.4% (continued strength), ACHN +2.5% (continued strength), SFXE +2.3% ( Acquires 50% of Rock in Rio for $62.3 mln), INO +1.9% (was under pressure in afternoon trade), GALE +1.6% (CEO at Leerink Conference addresses negative blog article published today: 'just another in a long line of these'), CASY +0.6% (to acquire 24 Stop-n-Go Stores; 'acquisition will be accretive to earnings in the first year of operation'), SFG +0.6% (announces new 3 mln share repurchase authorization ), HOLX +0.4% (CEO discloses buying 38.6K shares at $20.97-21.71 on 2/10-2/11, worth ~$800K).
Analyst comments: NSPH +1.3% (upgraded to Buy from Neutral at ROTH Capital) ANR +0.8% (upgraded to Neutral from Underperform at Macquarie; resumed with Neutral at JP Morgan).